Skip to Content

CREON 1236 (Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease)

Generic Name: pancrelipase

Pill with imprint CREON 1236 is Blue / Clear, Capsule-shape and has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease. It is supplied by AbbVie, Inc..

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1236

Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease CREON 1236
Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease CREON 1236
Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease CREON 1236

Creon

Generic Name
pancrelipase
Imprint
CREON 1236
Strength
180,000 units amylase / 36,000 units lipase / 114,000 units protease
Color
Blue / Clear
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AbbVie, Inc.
National Drug Code (NDC)
00032-3016

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.